Results 91 to 100 of about 4,078 (132)

Molecular Deconvolution of Circulating "Other Cells": A Reliable Predictive Marker of Therapy Response and Survival in Neuroendocrine Tumor Patients Receiving ¹⁷⁷Lu-DOTATATE PRRT. [PDF]

Cancer Med
Padwal MK, Parghane RV, Basu S, Basu B.
europepmc   +1 more source

Validation of Simplified Renal Dosimetry Protocols for ¹⁷⁷Lu-DOTATATE Therapy Using the IDAC-dose Software. [PDF]

Mol Imaging Radionucl Ther
Yokouchi A, Shibutani T, Konishi T, Yoneyama H, Ichikawa H, Wakabayashi H.   +5 more
europepmc   +1 more source

A case of renal primary neuroendocrine tumor (G3) in which 177Lu-PRRT was effective for disease control. [PDF]

Urol Case Rep
Inaba S, Kijima T, Takaoka M, Uematsu T, Takei K, Yashi M, Ishida K, Aoki T, Kamai T.   +8 more
europepmc   +1 more source

Spinal decompression and radionuclide therapy for an unresectable FGF23 transmitted tumor causing cervical myelopathy: a case report and literature review. [PDF]

Front Oncol
Yokoyama S, Shimizu H, Yuno A, Takenaka J, Wakabayashi N, Watanabe S, Kuwahara K, Matsuoka M, Onodera T, Iwasaki N, Iwata A.   +10 more
europepmc   +1 more source

Real-World Effectiveness of Capecitabine and Temozolomide Across Endocrine and Neuroendocrine Neoplasm Subtypes (ENENs): A Population-Based Cohort Study from Alberta, Canada (2011-2021). [PDF]

Curr Oncol
Aleksi A, Jobin KD, Hannouf MB, Husi P, Halperin H, White-Gloria C, Abedin T, Ruether D.   +7 more
europepmc   +1 more source

Somatostatin receptor PET-guided treatment and artificial intelligence applications in meningioma: a comprehensive review. [PDF]

Am J Nucl Med Mol Imaging
Gujral J, Gandhi OH, Amanullah AA, Singh SB, Ayubcha C, Werner TJ, Revheim ME, Alavi A.   +7 more
europepmc   +1 more source

Successful management and 10-year survival of a rectal neuroendocrine tumor with rare systemic metastases via a non-portal venous pathway. [PDF]

Clin J Gastroenterol
Horiguchi S, Matsumoto K, Miyamoto K, Matsumi A, Terasawa H, Fujii Y, Takagi K, Kuise T, Tanaka T, Otsuka M.   +9 more
europepmc   +1 more source

Paving the Way for CCK2R-Targeted Peptide Receptor Radionuclide Therapy with [¹⁷⁷Lu]Lu-DOTA-MGS5 in Patients with Small Cell Lung Cancer. [PDF]

Pharmaceutics
Zavvar TS, Santo G, Gruber L, Kronthaler A, Hagenbuchner J, Skvortsova I, Piro I, Steiger K, Martinovic V, Minasch D, Löffler-Ragg J, di Santo G, Virgolini IJ, von Guggenberg E.   +13 more
europepmc   +1 more source

Multimodal strategies for diagnosing and treating thyroid cancer: Advances in basic and clinical research. [PDF]

Transl Oncol
Zhao Y, Su Y, Wu Y, Mourdi N, Ji Y, Wang Z.   +5 more
europepmc   +1 more source

Treatment attrition between lines of therapy and its impact on outcomes for well-differentiated neuroendocrine tumors in British Columbia. [PDF]

ESMO Gastrointest Oncol
Fedrigo R, do Amaral Miranda T, D'Alpino Peioxoto R, Gill S, Benard F, Wilson D, Martineau P, Alberts I, Solar Vasconcelos JP, Loree JM.   +9 more
europepmc   +1 more source